# Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population

> **NCT00207935** · PHASE4 · COMPLETED · sponsor: **Children's National Research Institute** · enrollment: 20 (estimated)

## Conditions studied

- Epilepsy
- Mental Retardation
- Developmental Disabilities

## Interventions

- **BEHAVIORAL:** Swallow instruction

## Key facts

- **NCT ID:** NCT00207935
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207935, "Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00207935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*